Co-Diagnostics Inc [CODX] stock prices are down -0.13% to $0.46 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The CODX shares have gain 4.99% over the last week, with a monthly amount drifted -24.20%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Co-Diagnostics Inc [NASDAQ: CODX] stock has seen the most recent analyst activity on August 12, 2022, when Sidoti downgraded its rating to a Neutral but kept the price target unchanged to $5 for it. Previously, Sidoti started tracking the stock with Buy rating on December 29, 2021, and set its price target to $14. On March 29, 2021, downgrade downgraded it’s rating to Hold. Maxim Group upgraded its rating to a Buy. H.C. Wainwright reiterated its recommendation of a Buy and raised its price target to $35 on May 18, 2020. H.C. Wainwright reiterated a Buy rating for this stock on March 09, 2020, and upped its price target to $20. In a note dated March 03, 2020, Maxim Group downgraded an Hold rating on this stock.
The stock price of Co-Diagnostics Inc [CODX] has been fluctuating between $0.43 and $2.23 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Co-Diagnostics Inc [NASDAQ: CODX] shares were valued at $0.46 at the most recent close of the market. An investor can expect a potential return of 1204.35% based on the average CODX price forecast.
Analyzing the CODX fundamentals
The Co-Diagnostics Inc [NASDAQ:CODX] reported sales of 4.18M for trailing twelve months, representing a drop of -91.58%. Gross Profit Margin for this corporation currently stands at -0.02% with Operating Profit Margin at -9.26%, Pretax Profit Margin comes in at -8.11%, and Net Profit Margin reading is -8.96%. To continue investigating profitability, this company’s Return on Assets is posted at -0.57, Equity is -0.55 and Total Capital is -0.64. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4167 points at the first support level, and at 0.3703 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5047, and for the 2nd resistance point, it is at 0.5463.
Ratios To Look Out For
It’s worth pointing out that Co-Diagnostics Inc [NASDAQ:CODX]’s Current Ratio is 6.92. On the other hand, the Quick Ratio is 6.70, and the Cash Ratio is 1.86. Considering the valuation of this stock, the price to sales ratio is 3.54, the price to book ratio is 0.23.
